Markets:

Overview

News

Currencies

International

Treasuries

GRAIL, Inc. - Common Stock (NQ:GRAL)

137.51 -3.07 (-2.18%)

Delayed Quote Updated: 2:51 PM EDT, Oct 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GRAIL, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Why Grail Stock Soared 14% Higher on Thursday ↗

October 16, 2025

The company is receiving a significant equity investment as a component of a collaboration agreement with a large business partner.

Via The Motley Fool

Enerpac Tool Group Posts Upbeat Results, Joins Praxis Precision Medicines, J B Hunt, Salesforce And Other Big Stocks Moving Higher On Thursday ↗

October 16, 2025

Via Benzinga

This Cancer Detection Pioneer Is Worth a Look ↗

September 26, 2025

Multicancer detection tests are closing in on FDA approval and potentially major sales.

Via The Motley Fool

GRAIL INC (NASDAQ:GRAL) Reports Mixed Q2 2025 Earnings: Revenue Misses, Loss Narrows ↗

August 12, 2025

GRAIL Inc. (NASDAQ:GRAL) reported Q2 2025 results with revenue of $35.5M missing estimates, but a narrower EPS loss of -$3.18. Galleri test sales grew 21% YoY. Shares fell 2.6% post-earnings....

Via Chartmill

Earnings Scheduled For February 20, 2025 ↗

February 20, 2025

Via Benzinga

Earnings Scheduled For November 12, 2024 ↗

November 12, 2024

Via Benzinga

GRAL Stock Earnings: GRAIL Reported Results for Q2 2024 ↗

August 15, 2024

GRAIL just reported results for the second quarter of 2024.

Via InvestorPlace

Earnings Scheduled For August 12, 2025 ↗

August 12, 2025

Via Benzinga

Wall Street Rises Ahead Of Fed, Payment Stocks Fall On Stablecoin Bill: What's Driving Markets Wednesday? ↗

June 18, 2025

U.S. stocks inched higher by midday Wednesday, as traders weighed geopolitical uncertainty and awaited the Federal Reserve's June policy decision.

Via Benzinga

Topics Economy

3 Medical Technology Stocks Outperforming in 2025

June 09, 2025

Three med-tech stocks, TransMedics, Insulet, and GRAIL, are outperforming the market and their sector while forming bullish technical patterns.

Via MarketBeat

Shake Shack, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

May 19, 2025

Via Benzinga

Market Monitor News May 15 ( eToro, Oklo UP - Grail, American Eagle Outfitters DOWN) ↗

May 15, 2025

Wall Street pauses after weeks of gains. Nvidia leads tech rally, eToro soars on IPO, and Boeing lands record order amid Trump’s Middle East tour.

Via Chartmill

Topics Government Initial Public Offering

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 14, 2025

Via Benzinga

Alcon, American Eagle, GRAIL And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

May 14, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 14, 2025

Via Benzinga

Why Everus Construction Group Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket ↗

May 14, 2025

Via Benzinga

Top movers in Tuesday's after hours session ↗

May 13, 2025

The US market regular session of Tuesday is over, let's have a look at the top gainers and losers in the after hours session today.

Via Chartmill

Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence ↗

April 22, 2025

Quest Diagnostics Q1 2025 revenue rose to $2.65 billion with EPS of $2.21, exceeding expectations; full-year guidance for sales and EPS reaffirmed.

Via Benzinga

Earnings Scheduled For May 13, 2025 ↗

May 13, 2025

Via Benzinga

Jim Cramer Asks Trump To Take Stock As Markets Swing Again Ahead Of 'Liberation Day' ↗

March 31, 2025

US Markets continued to witness volatility on Monday as President Donald Trump's 'Liberation Day' fast approaches, bringing a volley of tariffs across products, industries, allies, and adversaries....

Via Benzinga

Topics Government World Trade

Jim Cramer: Healthpeak Properties Is A 'Reasonable' REIT, Recommends Buying This Health Care Stock ↗

March 28, 2025

Via Benzinga

Wondering what's happening in today's after-hours session? ↗

February 20, 2025

As the regular session of the US market on Thursday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

Via Chartmill

Top 5 Biotech Stocks That Got Most Retail Buzz Last Week ↗

February 17, 2025

From merger updates to earnings surprises, these healthcare stocks saw the biggest spike in Stocktwits chatter.

Via Stocktwits

Grail Shares Spiked Wednesday: What's Going On? ↗

February 12, 2025

Grail shares are trading higher Wednesday after the company announced a new collaboration with Quest Diagnostics aimed at improving provider access to its Galleri multi-cancer early detection test.

Via Benzinga

Jim Cramer Recommends Buying 'Fabulous' BlackRock, Calls Coterra Energy The 'Cheapest' Natural Gas Company ↗

January 28, 2025

Cramer comments on Danaher, Coterra, BlackRock and Digital Realty. As for Grail, "Just great science, but it is parabolic," he adds.

Via Benzinga

Topics Energy

Seagate Posts Upbeat Earnings, Joins Netflix, Travelers, Teledyne Technologies And Other Big Stocks Moving Higher On Wednesday ↗

January 22, 2025

Via Benzinga

What's Going On With Illumina Stock On Monday? ↗

December 16, 2024

Illumina exits Nasdaq-100, reports Q3 EPS of $1.14 beating estimates, faces macroeconomic challenges, and lowers 2024 revenue guidance.

Via Benzinga

GRAIL: Biotech Stock Targeting $100B Cancer Market

December 14, 2024

GRAIL is a small biotech stock on the rise big time recently. Its innovative technology gives it the opportunity to capitalize on a massive addressable market.

Via MarketBeat

Topics Death

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 14, 2024

Via Benzinga

European Court Rules In Favor Of Illumina In Fight Against Probe Into Grail Deal, Asks Not To Pay $478M Fine ↗

September 03, 2024

Illumina welcomes the European Court of Justice ruling that the European Commission lacked jurisdiction over its acquisition of GRAIL, confirming Illumina's stance. The ruling nullifies a €432 million...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.